Topiramate produced weight loss following olanzapine-induced weight gain in schizophrenia.
Levy
Emmanuelle
E
Margolese
Howard C
HC
Chouinard
Guy
G
D000328:Adult; D000927:Anticonvulsants / Q000008:administration & dosage* / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001569:Benzodiazepines; D015992:Body Mass Index; D004359:Drug Therapy, Combination; D005632:Fructose / Q000008:administration & dosage* / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D008297:Male; D000077152:Olanzapine; D010890:Pirenzepine / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives*; D012563:Schizophrenia, Paranoid / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D000077236:Topiramate; D015430:Weight Gain / Q000187:drug effects*
D000927:Anticonvulsants; D014150:Antipsychotic Agents; D000077236:Topiramate; D001569:Benzodiazepines; D005632:Fructose; D010890:Pirenzepine; D000077152:Olanzapine